• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia.

作者信息

Mordaunt Dylan A, Dalziel Kim, Goranitis Ilias, Stark Zornitza

机构信息

Health Economics Group, School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

出版信息

Eur J Hum Genet. 2023 Sep;31(9):977-979. doi: 10.1038/s41431-023-01417-6. Epub 2023 Jul 3.

DOI:10.1038/s41431-023-01417-6
PMID:37400487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10474079/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732d/10474079/afc628dd178c/41431_2023_1417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732d/10474079/afc628dd178c/41431_2023_1417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732d/10474079/afc628dd178c/41431_2023_1417_Fig1_HTML.jpg

相似文献

1
Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia.澳大利亚针对综合征性和非综合征性智力残疾的资助基因组检测的接受情况。
Eur J Hum Genet. 2023 Sep;31(9):977-979. doi: 10.1038/s41431-023-01417-6. Epub 2023 Jul 3.
2
50 Years Ago in TheJournalofPediatrics: Syndromic Intellectual Disability: A Never-Ending Genomic Odyssey.50年前发表于《儿科学杂志》：综合征性智力残疾：一场永无止境的基因组探索之旅。
J Pediatr. 2021 Apr;231:109. doi: 10.1016/j.jpeds.2020.11.038.
3
De novo deletion of FMN2 in a girl with mild non-syndromic intellectual disability.一名患有轻度非综合征性智力障碍女孩中FMN2的新生缺失。
Eur J Med Genet. 2013 Dec;56(12):686-8. doi: 10.1016/j.ejmg.2013.10.003. Epub 2013 Oct 24.
4
Non-syndromic X linked intellectual disability: Current knowledge in light of the recent advances in molecular and functional studies.X 连锁非综合征性智力障碍：分子和功能研究新进展的现状。
Clin Genet. 2020 May;97(5):677-687. doi: 10.1111/cge.13698. Epub 2020 Jan 9.
5
Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability.比较唾液和血液检测综合征性智力障碍相关嵌合基因组异常。
Eur J Hum Genet. 2023 May;31(5):521-525. doi: 10.1038/s41431-022-01232-5. Epub 2022 Nov 29.
6
A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.ZMYND11（10p15.3缺失综合征的候选基因）中的一个新发突变与综合征性智力残疾相关。
Eur J Med Genet. 2014 Nov-Dec;57(11-12):636-8. doi: 10.1016/j.ejmg.2014.09.002. Epub 2014 Sep 30.
7
Testing scenario for intellectual disability, developmental delay, and autism challenged.针对智力障碍、发育迟缓及自闭症的测试方案。
Am J Med Genet A. 2018 Jan;176(1):7-8. doi: 10.1002/ajmg.a.38587.
8
High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.靶向二代测序对综合征性智力障碍的诊断率高。
J Med Genet. 2017 Feb;54(2):87-92. doi: 10.1136/jmedgenet-2016-103964. Epub 2016 Sep 12.
9
Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists.智力残疾精神病学中的基因检测：英国儿童及智力残疾精神病医生的观点与实践
J Appl Res Intellect Disabil. 2018 Mar;31(2):273-284. doi: 10.1111/jar.12391. Epub 2017 Aug 23.
10
Exome sequencing and the genetics of intellectual disability.外显子组测序与智力障碍的遗传学。
Clin Genet. 2011 Aug;80(2):117-26. doi: 10.1111/j.1399-0004.2011.01720.x. Epub 2011 Jun 15.

引用本文的文献

1
Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation.主流医疗保健中用于罕见病的基因组测序技术：实施现状
Eur J Hum Genet. 2025 Aug 22. doi: 10.1038/s41431-025-01925-7.
2
Barriers and Breakthroughs in Precision Oncology: A National Registry Study of Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR).精准肿瘤学中的障碍与突破：一项基于国家妇科肿瘤登记处（NGOR）女性检测及PARP抑制剂使用情况的全国登记研究
Cancers (Basel). 2025 Jul 31;17(15):2541. doi: 10.3390/cancers17152541.
3
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.

本文引用的文献

1
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.澳大利亚基因组学：5 年国家计划加速基因组学在医疗保健中的整合的结果。
Am J Hum Genet. 2023 Mar 2;110(3):419-426. doi: 10.1016/j.ajhg.2023.01.018.
2
Closing the Gap in Cancer Genomic Testing.缩小癌症基因组检测差距。
N Engl J Med. 2022 Dec 8;387(23):2107-2110. doi: 10.1056/NEJMp2210638. Epub 2022 Dec 3.
3
Investigating disparity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people.
基因组医学中的分布成本效益分析：解决健康公平问题的考量因素
Value Health. 2025 May 6. doi: 10.1016/j.jval.2025.04.2162.
4
Opportunities and challenges for paediatricians requesting funded genomic tests for children.为儿童申请资助基因检测的儿科医生所面临的机遇与挑战。
Eur J Hum Genet. 2025 May 7. doi: 10.1038/s41431-025-01864-3.
5
International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease.国际精准儿童健康伙伴关系（IPCHiP）：一项加速罕见儿科疾病发现并改善治疗结果的倡议。
NPJ Genom Med. 2025 Feb 27;10(1):13. doi: 10.1038/s41525-025-00474-8.
6
Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014-2023.2014 - 2023年在公共资助的医疗保健系统中使用补贴的基因和基因组检测
Eur J Hum Genet. 2025 Feb 5. doi: 10.1038/s41431-025-01801-4.
7
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data.接受遗传疾病评估儿童家庭的基因检测应用情况及费用：基于美国商业索赔数据的分析
Appl Health Econ Health Policy. 2025 May;23(3):519-530. doi: 10.1007/s40258-024-00942-9. Epub 2025 Jan 8.
8
Non-geneticist champions are essential to the mainstreaming of genomic medicine.非遗传学家倡导者对于基因组医学的主流化至关重要。
Eur J Hum Genet. 2025 Jan 3. doi: 10.1038/s41431-024-01780-y.
9
A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders.基于质谱的定量蛋白质组学检测在用于线粒体和其他罕见疾病诊断流程中的微成本研究。
Orphanet J Rare Dis. 2024 Nov 29;19(1):443. doi: 10.1186/s13023-024-03462-w.
10
Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services.罕见病基因组数据的再分析：澳大利亚临床和实验室遗传学服务的当前实践和态度。
Eur J Hum Genet. 2024 Nov;32(11):1428-1435. doi: 10.1038/s41431-024-01633-8. Epub 2024 May 25.
调查澳大利亚临床遗传健康服务中，原住民和托雷斯海峡岛民获得服务的差距。
Nat Commun. 2022 Aug 24;13(1):4966. doi: 10.1038/s41467-022-32707-0.
4
Measuring physician practice, preparedness and preferences for genomic medicine: a national survey.测量医生的实践、准备情况和对基因组医学的偏好：一项全国性调查。
BMJ Open. 2021 Jul 9;11(7):e044408. doi: 10.1136/bmjopen-2020-044408.
5
Availability and funding of clinical genomic sequencing globally.全球临床基因组测序的可及性和资金情况。
BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-004415.
6
Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis.英国国民保健制度中基因组医学的实施：系统评价和叙述性综合。
Genet Med. 2019 Dec;21(12):2667-2675. doi: 10.1038/s41436-019-0579-x. Epub 2019 Jun 12.
7
Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.外显子组测序对疑似单基因疾病的长期经济影响：诊断、管理和生殖结局。
Genet Med. 2019 Nov;21(11):2586-2593. doi: 10.1038/s41436-019-0534-x. Epub 2019 May 21.
8
Integrating Genomics into Healthcare: A Global Responsibility.将基因组学融入医疗保健：全球的责任。
Am J Hum Genet. 2019 Jan 3;104(1):13-20. doi: 10.1016/j.ajhg.2018.11.014.
9
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.临床全外显子组测序与常规护理的成本效益的前瞻性比较压倒性地支持早期使用和报销。
Genet Med. 2017 Aug;19(8):867-874. doi: 10.1038/gim.2016.221. Epub 2017 Jan 26.
10
Factors influencing organizational adoption and implementation of clinical genetic services.影响临床遗传服务组织采用和实施的因素。
Genet Med. 2014 Mar;16(3):238-45. doi: 10.1038/gim.2013.101. Epub 2013 Aug 15.